health
Weight loss and hair loss: The growing hair treatment market from GLP-1s
A common side effect of many GLP-1 drugs is hair loss. It's creating a formerly untapped but growing market for hair treatment products.
TL;DR
- Hair loss is a common side effect of GLP-1 weight-loss drugs like Mounjaro, Zepbound, Ozempic, and Wegovy.
- This side effect has created a growing market for hair treatment products, with brands like Redken, Nutrafol, and KeraFactor innovating and marketing in this space.
- Retailers such as Ulta are observing increased demand for hair growth solutions from customers using GLP-1 medications.
- Experts suggest the intersection of health, wellness, and beauty related to this trend offers attractive investment opportunities.
- The use of GLP-1 drugs has more than doubled, with estimates suggesting 25 million Americans will be on them by 2030.
- Dermatologists explain that significant weight loss, including that from GLP-1s, can lead to hair loss due to nutrient deficiencies and the stress of bodily changes.
- Consumers using GLP-1s are reportedly spending more on beauty products, with hair loss solutions being a standout growth segment.
- The hair loss experienced can be a significant stressor, increasing the demand for at-home growth treatments, scalp serums, and supplements.
- Companies are developing specific product lines tested on GLP-1 users, reporting positive results in hair fullness and thickness.
- Customers in this market are expected to be loyal due to the time it takes for hair treatments to show results.